Nasdaq Initiates Delisting Process for Dyadic International After Missed Compliance Deadline
Summary
Nasdaq has initiated a delisting process for Dyadic International after the company failed to meet the minimum bid price requirement and did not qualify for an extension.
Key Events
-
Nasdaq Initiates Delisting Process
On June 18, 2026, Nasdaq notified Dyadic International that it has initiated a process that could result in the delisting of the company's securities.
-
Failed Bid Price Compliance
The company failed to regain compliance with Nasdaq Listing Rule 5450(a)(1), which requires a minimum bid price of $1.00 per share, by the June 17, 2026 deadline.
-
Did Not Qualify for Extension
Dyadic International did not meet the condition for an additional 180-day extension, which required shareholders' equity of at least $5 million.
-
Additional Delisting Basis Cited
Nasdaq also cited the company's failure to comply with Listing Rule 5550(b), requiring minimum shareholders' equity of $2.5 million, market value of $35 million, or $500,000 net income.
Analysis
Nasdaq has formally initiated delisting proceedings against Dyadic International because the company failed to regain compliance with the $1.00 minimum bid price rule by the June 17, 2026 deadline. Crucially, the company also did not meet the $5 million shareholders' equity requirement to qualify for an extension, intensifying the risk of delisting. This development significantly impacts the company's ability to maintain its public listing, which is critical for liquidity and future capital raising efforts, especially given its negative shareholder equity reported in Q1 2026.
At the time of this filing, DYAI was trading at $0.85 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $30.9M. The 52-week trading range was $0.65 to $1.35. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.